Transient exposure to tumor necrosis factor-α inhibits collagen accumulation by cultured hypertrophic scar fibroblasts

Journal of Surgical Research

Volumn 87, Issue 1, 1999, Pages 134-141

  Kitzis, Vanessa ^a,b   Engrav, Loren H ^a   Quinn, Lebris S ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

Cell culture; Collagen; Hypertrophic scar; Insulin like growth factor binding proteins; Tumor necrosis factor

Indexed keywords

COLLAGEN; SOMATOMEDIN BINDING PROTEIN 3; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CULTURE; CELL STIMULATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; HYPERTROPHIC SCAR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS; WOUND HEALING;

EID: 0032693003     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1999.5747     Document Type: Article

References (39)

1. Tredget E. E., Nedelec B., Scott P. G., Ghahary A. Hypertrophic scars, keloids, and contractures: The cellular and molecular basis for therapy. Surg. Clin. North Am. 77:1997;701.
2. Engrav L. H., Covey M. H., Dutcher K. D., Heimbach D. M., Walkinshaw M. D., Marvin J. A. Impairment, time out of school, and time off from work after burns. Plast. Reconstr. Surg. 79:1987;927.
3. Blackburn W. R., Cosman B. Histologic basis of keloid and hypertrophic scar differentiation. Arch. Pathol. 82:1966;65.
4. Rudolph R. Wide spread scars, hypertrophic scars, and keloids. Clin. Plast. Surg. 14:1987;253.
5. Ghahary A., Shen Y. J., Scott P. G., Gong Y., Tredget E. E. Enhanced expression of mRNA for transforming growth factor-β, type I and type III procollagen in human postburn hypertrophic scar tissues. J. Lab. Clin. Med. 122:1993;465.
6. 1 mRNA and protein in hypertrophic burn scar. J. Invest. Dermatol. 104:1995;750.
7. Garner W. L., Karmiol S., Rodriguez J. L., Smith D. J., Phan S. H. Phenotypic differences in cytokine responsiveness of hypertrophic scar versus normal dermal fibroblasts. J. Invest. Dermatol. 101:1993;875.
8. Mauviel A., Heino J., Kahari V. M., Harmann D. J., Loyau G., Pujol J.-P., Vuorio E. Comparative effects of interleukin-1 and tumor necrosis factor-α on collagen production and corresponding procollagen mRNA levels in human dermal fibroblasts. J. Invest. Dermatol. 96:1991;243.
9. Border W. A., Noble N. A. Transforming growth factor β in tissue fibrosis. N. Engl. J. Med. 331:1994;1286.
10. Polo M., Ko F., Busillo F., Cruse C. W., Krizek T. J., Robson M. C. Cytokine production in patients with hypertrophic burn scars. J. Burn Care Rehabil. 18:1997;477.
11. Peruccio D., Castagnoli C., Stella M., D'Alfonso S., Richiardi Momigliano P., Magliacani G., Teich Alasia S. Altered biosynthesis of tumour necrosis factor (TNF) alpha is involved in postburn hypertrophic scars. Burns. 20:1994;118.
12. Ignotz R. A., Massague J. Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J. Biol. Chem. 261:1986;4337.
13. Reed M. J., Vernon R. B., Abrass I. B., Sage E. H. TGF-β1 induces the expression of type I collagen and SPARC, and enhances contraction of collagen gels, by fibroblasts from young and aged donors. J. Cell. Physiol. 158:1994;169.
14. Bird J. L. E., Tyler J. A. Tumour necrosis factor α, interferon γ and dexamethasone regulate IGF-I maintained collagen production in cultured human fibroblasts. J. Endocrinol. 147:1995;167.
15. Rapala K. T., Vaha-Kreula M. O., Vuorio E. I., Laato M. K. Tumor necrosis factor-α inhibits collagen synthesis in human and rat granulation tissue fibroblasts. Experientia. 52:1996;70.
16. Hathaway C. L., Arnold A. M., Rand R. P., Engrav L. H., Quinn L. S. Differential expression of IGFBPs by normal and hypertrophic scar fibroblasts. J. Surg. Res. 60:1996;156.
17. Yateman M. E., Claffey D. C., Cwyfan Hughes S. C., Frost V. J., Wass J. A. H., Holly J. M. P. Cytokines modulate the sensitivity of human fibroblasts to stimulation with insulin-like growth factor-I (IGF-I) by altering IGF-binding protein production. J. Endocrinol. 137:1993;151.
18. Gucev Z. S., Oh Y., Kelley K. M., Rosenfeld R. G. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor β2-induced growth inhibition in human breast cancer cells. Cancer Res. 56:1996;1545.
19. 1 on programmed cell death through a p53- and IGF-independent mechanism. J. Biol. Chem. 272:1997;12181.
20. Birnbaum R. S., Wiren K. Changes in insulin-like growth factor-binding protein expression and secretion during the proliferation, differentiation, and mineralization of primary cultures of rat osteoblasts. Endocrinology. 135:1994;223.
21. Hossenlopp P., Seurin D., Segovia-Quinson B., Hardouin S., Binoux M. Analysis of serum insulin-like growth factor binding proteins using Western blotting: Use of the method for titration of the binding proteins and competitive binding studies. Anal. Biochem. 154:1986;138.
22. Harper R. A., Grove G. Human skin fibroblasts derived from papillary and reticular dermis: Differences in growth potential in vitro. Science. 204:1979;526.
23. Frost R. A., Lang C. H., Gelato M. C. Transient exposure of human myoblasts to tumor necrosis factor-α inhibits serum and insulin-like growth factor-I stimulated protein synthesis. Endocrinology. 138:1997;4153.
24. Castagnoli C., Stella M., Teich Alasia S., Richiardi P. M. Anomolous expression of HLA class II molecules on keratinocytes and fibroblasts in hypertrophic scars consequent to thermal injury. Clin. Exp. Immunol. 82:1990;350.
25. Cracco C., Stella M., Teich Alasia S., Filogamo G. Comparative study of Langerhans cells in normal and pathological human scars. II. Hypertrophic scars. Eur. J. Histochem. 36:1992;53.
26. Castagnoli C., Stella M., Berthod C., Magliacani G., Richiardi P. M. TNF production and hypertrophic scarring. Cell. Immunol. 147:1993;51.
27. 2 production by human synovial cells and dermal fibroblasts. J. Exp. Med. 162:1985;2163.
28. Duncan M. R., Berman B. Differential regulation of collagen, glycosaminoglycan, fibronectin, and collagenase activity production in cultured human adult dermal fibroblasts by interleukin 1-alpha and beta and tumor necrosis factor-alpha and beta. J. Invest. Dermatol. 92:1989;699.
29. Tredget E. E., Shankowsky H. A., Pannu R., Nedelec B., Iwashina T., Ghahary A., Taerum T. V., Scott P. G. Transforming growth factor-β in thermally injured patients with hypertrophic scars: Effects of interferon α-2b. Plast. Reconstr. Surg. 102:1998;1317.
30. Zhou A., Chen Z., Rummage J.-A., Jiang H., Kolosov M., Kolosov I., Stewart C. A., Leu R. W. Exogenous interferon-gamma induces endogenous synthesis of interferon-alpha and -beta by murine macrophages for induction of nitric oxide synthase. J. Interferon Cytokine Res. 15:1995;897.
31. Shah M., Foreman D. M., Ferguson M. W. J. Neutralising antibody to TGF-β1,2 reduces cutaneous scarring in adult rodents. J. Cell Sci. 107:1994;1137.
32. Mustoe T. A., Pierce G. F., Thomason A., Gramates P., Sporn M. B., Deuel T. F. Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta. Science. 237:1987;1333.
33. Steenfos H. H., Hunt T. K., Scheuenstuhl H., Goodson W. H. Selective effects of tumor necrosis factor-alpha on wound healing in rats. Surgery. 106:1989;171.
34. Steenfos H., Spencer E., Hunt T. Insulin-like growth factor I has a major role in wound healing. Surg. Forum. 40:1989;68.
35. Ghahary A., Shen Q., Shen Y. J., Scott P. G., Tredget E. E. Induction of transforming growth factor β1 by insulin-like growth factor-1 in dermal fibroblasts. J. Cell. Physiol. 174:1998;301.
36. Rosenfeld R. G., Lamson G., Pham H. M., Oh Y., Conover C., De Leon D. D., Donovan S. M., Ocrant I., Giudice L. C. Insulin-like growth factor binding proteins. Recent Prog. Horm. Res. 46:1990;99.
37. Leal S. M., Liu Q., Huang S. S., Huang J. S. The type V transforming growth factor β receptor is the putative insulin-like growth factor-binding protein 3 receptor. J. Biol. Chem. 272:1997;20572.
38. Hamon G. A., Hunt T. K., Spencer E. M. In vivo effects of systemic insulin-like growth factor-I alone and complexed with insulin-like growth factor binding protein-3 on corticosteroid suprressed wounds. Growth Regul. 3:1993;53.
39. Fan J., Char D., Bagby G. J., Gelato M. C., Lang C. H. Regulation of insulin-like growth factor-I (IGF-I) and IGF binding proteins by tumor necrosis factor. Am. J. Physiol. 269:1995;R1204.